MEDRAD MVS(R) Announces New Ultrasound Probe Repair Facility in Denver
WARRENDALE, Pa., March 24 /PRNewswire/ -- MEDRAD, Inc. Multi Vendor Service has announced the opening of a repair facility in Denver, Colorado that specializes in 3D/4D ultrasound probes.
(Logo: http://www.newscom.com/cgi-bin/prnh/20100324/NE75594LOGO-a )
(Logo: http://www.newscom.com/cgi-bin/prnh/20100324/NE75594LOGO-b )
"The opening of the Denver operation is a response to our customers' need for a repair solution for their highly complex 3D/4D ultrasound probes," said Diane Watson, executive director of sales and marketing, MEDRAD Service. "The Denver team specializes in the complex technology that makes these probes unique and difficult to repair," Watson continues. "Their expertise will allow us to include more 3D/4D probes in our guaranteed repair offering, TotalRepair(SM)."
Investments in new capabilities such as these make it possible for MEDRAD to offer TotalRepair(SM), the first and only guaranteed repair solution for select ultrasound probes. Enabled by 100 percent repair capabilities, TotalRepair(SM) allows healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair. TotalRepair not only helps healthcare facilities reduce service costs, but also mitigate overall financial exposure with a capped, guaranteed "worst case scenario" price provided up front.
The Denver facility is owned and operated by Wetsco, Inc.
About MEDRAD Multi Vendor Service
Multi Vendor Service, a part of MEDRAD Service, provides third-party service for MRI coils, ultrasound transducers, dry imagers and CR systems. With high repair capabilities, a broad range of makes and models serviced, complimentary loaners and over 250 field-based personnel, MEDRAD offers significant value in third-party service. For more information about MVS, visit www.medrad.com/mvs. (800) MEDRAD-1, ext 5100. firstname.lastname@example.org
About MEDRAD, Inc.
MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
SOURCE MEDRAD, Inc. Multi Vendor Service